Procter & Gamble Hygiene and Health Care · NSE: PGHH · BSE: 500459
Q4 FY26 results · Jan–Mar 2026
Procter & Gamble Hygiene and Health Care reported revenue from operations of ₹941.32 crore and net profit of ₹153.13 crore for Q4 FY26 (Jan–Mar 2026), on a standalone basis.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 941.32 | — | — | 1,261.90 | −25.4% |
| Other income | 12.47 | — | — | 12.41 | +0.5% |
| Total income | 953.79 | — | — | 1,274.31 | −25.2% |
| Profit before tax | 218.11 | — | — | 402.04 | −45.7% |
| Net profit for the period | 153.13 | — | — | 301.46 | −49.2% |
| EPS, basic (₹) | 47.17 | — | — | 92.87 | −49.2% |
| Net margin (%) | 16.3 | — | 23.9 |
Standalone
- Filed with BSE
- 28 May 2026, 17:07 IST
- Board meeting
- 28 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE